Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRecord History shows a new revision entry: v3.3.2, replacing the previous v3.3.1. This is a minor metadata update to the page history.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.3.1 was added to the record history and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the government funding/operating status banner that warned about potential data delays. The page now presents the study record history without that operational-status message.SummaryDifference0.8%

- Check67 days agoChange DetectedThe two screenshots show the same version history entries with no new data; only minor layout differences are visible, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.